What is Bristol-Myers Squibb's current CEO?

Christopher S. Boerner, Ph.D, dated November 1, 2023, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95).

organization · fact

Bristol-Myers Squibb CEO

As of November 9, 2026, Bristol-Myers Squibb's CEO on the AsOf record is Christopher S. Boerner, Ph.D, dated November 1, 2023, from a primary source (sec.gov).

current CEO: Christopher S. Boerner, Ph.DNovember 1, 2023 · 1 source

Every dated value

1 value · 1 current

Bristol-Myers Squibb CEO: every dated value on the record, oldest first, with its dates, status, confidence and sources
value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	valid to	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
Christopher S. Boerner, Ph.D: CEO Christopher S. Boerner, Ph.D from 2023-11-01, claim clm_FF61856A3386 and its sources to present · sec.gov	2023-11-01	present	0.95	sec.gov

Questions this record answers

What is Bristol-Myers Squibb's current CEO?: Christopher S. Boerner, Ph.D, dated November 1, 2023, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95).

Answered from the rows above, as of November 9, 2026.

Cite Bristol-Myers Squibb CEO

Each form names the value, its as-of date (2023-11-01), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text

AsOf. "Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D", as of 2023-11-01. Claim clm_FF61856A3386, https://asof.is/claim/clm_FF61856A3386, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm.

APA

AsOf. (2023). Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D (as of 2023-11-01) [Record clm_FF61856A3386]. Retrieved November 9, 2026, from https://asof.is/claim/clm_FF61856A3386 (source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm)

BibTeX

@misc{asof_clm_FF61856A3386,
  author = {AsOf},
  title = {Bristol-Myers Squibb ceo: Christopher S. Boerner, Ph.D},
  year = {2023},
  howpublished = {\url{https://asof.is/claim/clm_FF61856A3386}},
  note = {Claim clm\_FF61856A3386, as of 2023-11-01; source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm},
  urldate = {2026-11-09}
}

Read on

/record/bristol-myers-squibb/ceo.md · this page as markdown
/facts/ceo · every company's CEO
/record/bristol-myers-squibb · /timelines/bristol-myers-squibb

Other facts about Bristol-Myers Squibb

Record